This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ galanthamine hydrobromide,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Improvement in Cognitive Function: Galanthamine hydrobromide has been shown to improve cognitive function, including memory, attention, and executive function, in patients with Alzheimer's disease and other forms of dementia. By inhibiting the breakdown of acetylcholine, it enhances cholinergic neurotransmission, which is impaired in Alzheimer's disease.

  2. Slowing of Disease Progression: While galanthamine hydrobromide does not cure Alzheimer's disease, it may help slow the progression of symptoms in some patients. By preserving acetylcholine levels and enhancing cholinergic neurotransmission, it may help maintain cognitive function and delay cognitive decline over time.

  3. Enhancement of Daily Functioning: Treatment with galanthamine hydrobromide may improve patients' ability to perform activities of daily living, such as dressing, grooming, and meal preparation, by helping to preserve cognitive function and independence.

  4. Reduction in Behavioral Symptoms: Galanthamine hydrobromide may also reduce behavioral and psychological symptoms associated with dementia, such as agitation, aggression, and hallucinations. By improving cognitive function and enhancing neurotransmission, it may help stabilize mood and behavior.

  5. Side Effects: Common side effects of galanthamine hydrobromide include nausea, vomiting, diarrhea, dizziness, headache, and decreased appetite. These side effects are usually mild to moderate in severity and often improve with continued use or dose adjustment.

  6. Cholinergic Side Effects: Due to its mechanism of action, galanthamine hydrobromide can cause cholinergic side effects, such as bradycardia, syncope, urinary incontinence, and exacerbation of asthma or obstructive pulmonary disease. Patients with underlying cardiovascular or respiratory conditions may be at higher risk for these side effects.

  7. Dosage and Titration: Galanthamine hydrobromide is typically initiated at a low dose and gradually titrated upward to minimize side effects and maximize therapeutic benefit. Close monitoring is required during dose titration to assess tolerability and response.

  8. Interactions: Galanthamine hydrobromide may interact with other medications, particularly those with anticholinergic properties, such as certain antidepressants, antipsychotics, and antihistamines. Concurrent use of these medications may increase the risk of cholinergic side effects.

  9. Contraindications: Galanthamine hydrobromide is contraindicated in patients with a history of hypersensitivity to the drug or its components, as well as in patients with severe liver or kidney impairment. It should be used with caution in patients with gastrointestinal disorders or urinary obstruction.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of galanthamine hydrobromide,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Akkermansia muciniphila Reduces
species Anaerobutyricum hallii Reduces
species Bifidobacterium adolescentis Reduces
species Bifidobacterium breve Reduces
species Bifidobacterium longum Reduces
species Christensenella minuta Reduces
species Escherichia coli Reduces
species Lactococcus cremoris Reduces
species Veillonella atypica Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by galanthamine hydrobromide,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Akkermansiaceae family Decreases
0 1 Blautia genus Decreases
0 1 Clostridioides genus Decreases
0 1 Clostridium genus Decreases
0 1 Roseburia genus Decreases
0 1 Collinsella genus Decreases
0 1 Eggerthella genus Decreases
0 1 Veillonella genus Decreases
0 1 Escherichia genus Decreases
0 1 Bifidobacterium genus Decreases
0 1 Odoribacter genus Decreases
0 1 Dorea genus Decreases
0 1 Bacteroides genus Decreases
0 1 Shigella genus Decreases
0 1 Streptococcus genus Decreases
0 1 Lachnospira genus Decreases
0 1 Ruminococcus genus Decreases
1 0 Akkermansia genus Decreases
0 1 Thomasclavelia genus Decreases
0 1 Coprococcus genus Decreases
0 1 Enterocloster genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Clostridium perfringens A no rank Decreases
0 1 Clostridium perfringens B no rank Decreases
0 1 Clostridium perfringens C no rank Decreases
0 1 Clostridium perfringens CPE no rank Decreases
0 1 Clostridium perfringens D no rank Decreases
0 1 Clostridium perfringens E no rank Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 environmental samples no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 Clostridium perfringens species Decreases
1 0 Blautia obeum species Decreases
1 0 Clostridioides difficile species Decreases
1 0 Roseburia hominis species Decreases
1 0 Collinsella aerofaciens species Decreases
1 0 Eggerthella lenta species Decreases
1 0 Bifidobacterium adolescentis species Decreases
1 0 Veillonella parvula species Decreases
1 0 Bacteroides xylanisolvens species Decreases
1 0 Escherichia coli species Decreases
1 0 Bacteroides ovatus species Decreases
1 0 Odoribacter splanchnicus species Decreases
1 0 Dorea formicigenerans species Decreases
1 0 Bacteroides caccae species Decreases
1 0 Bifidobacterium longum species Decreases
1 0 Streptococcus salivarius species Decreases
0 1 Veillonella rodentium species Decreases
0 1 Shigella dysenteriae species Decreases
0 1 Shigella flexneri species Decreases
0 1 Escherichia albertii species Decreases
0 1 Eggerthella guodeyinii species Decreases
0 1 Veillonella dispar species Decreases
0 1 Anaerobutyricum hallii species Decreases
0 1 Veillonella sp. S12025-13 species Decreases
0 1 Escherichia fergusonii species Decreases
0 1 Blautia sp. SC05B48 species Decreases
0 1 Veillonella nakazawae species Decreases
0 1 Coprococcus catus species Decreases
0 1 Parolsenella catena species Decreases
0 1 Wansuia hejianensis species Decreases
0 1 Dorea longicatena species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Komagataeibacter oboediens species Decreases
0 1 Bifidobacterium angulatum species Decreases
0 1 Parolsenella massiliensis species Decreases
0 1 Shigella boydii species Decreases
0 1 Veillonella rogosae species Decreases
0 1 Collinsella stercoris species Decreases
0 1 Qiania dongpingensis species Decreases
0 1 Ligilactobacillus ruminis species Decreases
0 1 Blautia liquoris species Decreases
1 0 Lachnospira eligens species Decreases
0 1 Butyrivibrio crossotus species Decreases
0 1 Novisyntrophococcus fermenticellae species Decreases
0 1 Faecalitalea cylindroides species Decreases
0 1 Clostridium sp. M62/1 species Decreases
0 1 Subdoligranulum variabile species Decreases
0 1 Lacrimispora saccharolytica species Decreases
0 1 Clostridium sp. SY8519 species Decreases
1 0 Streptococcus parasanguinis species Decreases
0 1 Streptococcus sp. FDAARGOS_192 species Decreases
1 0 Ruminococcus bromii species Decreases
0 1 Marvinbryantia formatexigens species Decreases
0 1 Eubacterium ventriosum species Decreases
0 1 Lachnoclostridium phocaeense species Decreases
0 1 Christensenella minuta species Decreases
0 1 Massilistercora timonensis species Decreases
0 1 Faecalibacterium duncaniae species Decreases
0 1 Ruminococcus gauvreauii species Decreases
0 1 Clostridium cadaveris species Decreases
0 1 Longicatena caecimuris species Decreases
0 1 Bacteroides sp. D2 species Decreases
0 1 [Ruminococcus] lactaris species Decreases
0 1 Veillonella atypica species Decreases
0 1 [Clostridium] hylemonae species Decreases
0 1 Catenibacterium mitsuokai species Decreases
0 1 Maliibacterium massiliense species Decreases
0 1 Eubacterium sp. MSJ-33 species Decreases
0 1 Solibaculum mannosilyticum species Decreases
0 1 Coprococcus eutactus species Decreases
0 1 [Ruminococcus] torques species Decreases
0 1 Lachnoanaerobaculum gingivalis species Decreases
0 1 Bacteroides sp. DH3716P species Decreases
0 1 Adlercreutzia equolifaciens species Decreases
0 1 Amedibacterium intestinale species Decreases
0 1 Gordonibacter urolithinfaciens species Decreases
0 1 Anaerostipes hadrus species Decreases
0 1 Vescimonas fastidiosa species Decreases
0 1 Faecalibacillus intestinalis species Decreases
0 1 Streptococcus suis species Decreases
0 1 Bifidobacterium breve species Decreases
0 1 Bacteroides sp. M10 species Decreases
0 1 Intestinibaculum porci species Decreases
0 1 Eubacterium sp. c-25 species Decreases
0 1 Faecalibacterium sp. I2-3-92 species Decreases
0 1 Monoglobus pectinilyticus species Decreases
0 1 Coprococcus sp. ART55/1 species Decreases
0 1 Parafannyhessea umbonata species Decreases
0 1 Arabiibacter massiliensis species Decreases
0 1 Shigella sonnei species Decreases
0 1 Lactococcus cremoris species Decreases
1 0 Akkermansia muciniphila species Decreases
1 0 Thomasclavelia ramosa species Decreases
1 0 Coprococcus comes species Decreases
1 0 Bacteroides thetaiotaomicron species Decreases
1 0 Enterocloster bolteae species Decreases
0 1 Akkermansia glycaniphila species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases
1 0 Mediterraneibacter gnavus species Decreases
0 1 Bifidobacterium longum subsp. infantis subspecies Decreases
0 1 Bifidobacterium longum subsp. longum subspecies Decreases
0 1 Bifidobacterium longum subsp. suillum subspecies Decreases
0 1 Bifidobacterium longum subsp. suis subspecies Decreases

Impact of galanthamine hydrobromide,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.1 0.1
Acne 0.2 -0.2
ADHD 2 0.6 2.33
Age-Related Macular Degeneration and Glaucoma 0.6 0.6
Allergic Rhinitis (Hay Fever) 1.7 1.8 -0.06
Allergies 4.8 1.5 2.2
Allergy to milk products 1.3 0.7 0.86
Alopecia (Hair Loss) 0.8 0.8
Alzheimer's disease 2.8 3.5 -0.25
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.2 0.6 1
Ankylosing spondylitis 2.4 0.3 7
Anorexia Nervosa 1.1 1.5 -0.36
Antiphospholipid syndrome (APS) 0.6 0.6
Asthma 3.5 1.6 1.19
Atherosclerosis 1.1 1 0.1
Atrial fibrillation 1.4 0.7 1
Autism 5.1 4.1 0.24
Autoimmune Disease 0.6 0.8 -0.33
Barrett esophagus cancer 0.2 0.1 1
benign prostatic hyperplasia 0.3 0.2 0.5
Biofilm 0.9 0.9
Bipolar Disorder 1.1 0.9 0.22
Brain Trauma 0.7 0.7 0
Breast Cancer 0.4 0.4
Cancer (General) 0.4 1.8 -3.5
Carcinoma 1.9 1.4 0.36
Celiac Disease 1.3 1.8 -0.38
Cerebral Palsy 1 0.9 0.11
Chronic Fatigue Syndrome 3.2 2.7 0.19
Chronic Kidney Disease 2.6 1.1 1.36
Chronic Lyme 0.6 0.4 0.5
Chronic Obstructive Pulmonary Disease (COPD) 1.1 0.7 0.57
Chronic Urticaria (Hives) 1.2 0.1 11
Coagulation / Micro clot triggering bacteria 0.8 0.9 -0.13
Cognitive Function 0.9 1 -0.11
Colorectal Cancer 3 1.7 0.76
Constipation 0.6 0.7 -0.17
Coronary artery disease 1.3 1.6 -0.23
COVID-19 6 6 0
Crohn's Disease 3.6 2.2 0.64
Cushing's Syndrome (hypercortisolism) 0.2 -0.2
cystic fibrosis 0.6 1.5 -1.5
d-lactic acidosis (one form of brain fog) 0.4 0.4
deep vein thrombosis 0.8 0.6 0.33
Denture Wearers Oral Shifts 0.8 0.8
Depression 5.2 4.6 0.13
Dermatomyositis 0.1 0.2 -1
Eczema 1 1.3 -0.3
Endometriosis 1.8 1.3 0.38
Eosinophilic Esophagitis 0.3 -0.3
Epilepsy 2.6 0.9 1.89
erectile dysfunction 0.8 0.2 3
Fibromyalgia 1.7 0.7 1.43
Functional constipation / chronic idiopathic constipation 2.5 1.9 0.32
gallstone disease (gsd) 1.8 0.5 2.6
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.2 1.2 -5
Generalized anxiety disorder 1.7 1.1 0.55
giant cell arteritis 0.3 -0.3
Glioblastoma 0.1 -0.1
Gout 1.1 0.5 1.2
Graves' disease 0.9 2 -1.22
Gulf War Syndrome 0.8 0.4 1
Halitosis 0.5 0.1 4
Hashimoto's thyroiditis 1.8 0.6 2
Heart Failure 2.1 1.2 0.75
hemorrhagic stroke 0.2 0.2
Hidradenitis Suppurativa 0.3 0.2 0.5
High Histamine/low DAO 1.6 0.3 4.33
hypercholesterolemia (High Cholesterol) 0.9 0.1 8
hyperglycemia 1.5 0.9 0.67
Hyperlipidemia (High Blood Fats) 0.5 0.3 0.67
hypersomnia 0.7 -0.7
hypertension (High Blood Pressure 2 3 -0.5
Hypothyroidism 0 0.9 0
Hypoxia 1.5 1.5
IgA nephropathy (IgAN) 0.6 2.2 -2.67
Inflammatory Bowel Disease 6 5.1 0.18
Insomnia 1.5 1.5 0
Intelligence 1.1 1.1
Intracranial aneurysms 0.6 0.3 1
Irritable Bowel Syndrome 4.3 2.2 0.95
ischemic stroke 1.9 0.8 1.37
Liver Cirrhosis 4.3 2.1 1.05
Long COVID 3 4.4 -0.47
Low bone mineral density 0.6 -0.6
Lung Cancer 0.6 0.9 -0.5
Lymphoma 0.3 0.3
Mast Cell Issues / mastitis 0.4 0.3 0.33
ME/CFS with IBS 0.4 1.8 -3.5
ME/CFS without IBS 1.3 1 0.3
membranous nephropathy 0.1 0.1
Menopause 1.6 0.3 4.33
Metabolic Syndrome 4.1 3.9 0.05
Mood Disorders 5.9 3.8 0.55
multiple chemical sensitivity [MCS] 0.6 0.4 0.5
Multiple Sclerosis 4.2 2.7 0.56
Multiple system atrophy (MSA) 0.8 0.7 0.14
myasthenia gravis 0.4 0.6 -0.5
neuropathic pain 0.2 1.5 -6.5
Neuropathy (all types) 0.8 0.8 0
neuropsychiatric disorders (PANDAS, PANS) 0.7 0.7
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 3.3 3 0.1
NonCeliac Gluten Sensitivity 1.4 0.3 3.67
Obesity 5.7 3.7 0.54
obsessive-compulsive disorder 3.1 1.4 1.21
Osteoarthritis 1.6 0.7 1.29
Osteoporosis 1.6 1 0.6
pancreatic cancer 0.3 0.1 2
Parkinson's Disease 5.1 2.8 0.82
Polycystic ovary syndrome 2.6 1.8 0.44
Postural orthostatic tachycardia syndrome 0.3 0.2 0.5
Premenstrual dysphoric disorder 0.9 0.9
primary biliary cholangitis 0.5 0.7 -0.4
Primary sclerosing cholangitis 1.6 1.7 -0.06
Psoriasis 2.6 0.6 3.33
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 3.6 2.2 0.64
Rosacea 0.4 0.6 -0.5
Schizophrenia 4.4 1.8 1.44
scoliosis 0.6 0.2 2
sensorineural hearing loss 0.3 0.3
Sjögren syndrome 1.8 1.4 0.29
Sleep Apnea 1 1.1 -0.1
Slow gastric motility / Gastroparesis 0.9 0.2 3.5
Small Intestinal Bacterial Overgrowth (SIBO) 1.2 0.3 3
Stress / posttraumatic stress disorder 1.7 1.5 0.13
Systemic Lupus Erythematosus 2 1.3 0.54
Tic Disorder 0.3 0.9 -2
Tourette syndrome 0.3 0.2 0.5
Type 1 Diabetes 2.1 2.2 -0.05
Type 2 Diabetes 4 3.1 0.29
Ulcerative colitis 3.1 3.2 -0.03
Unhealthy Ageing 1.7 0.7 1.43
Vitiligo 0.6 0.6 0

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]